Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02201992
Brief Title: Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

First Submitted : July 21, 2014
First Submitted that Met QC Criteria : July 24, 2014
First Posted : July 28, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : May 17, 2019
Last Update Posted : May 20, 2019